Leaderboards/Parkinson's Disease and Spinal Disorders

Parkinson's Disease and Spinal Disorders

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Linda Remijn‐Nelissen
Leiden University Medical Center
2
Derin Marbin
Humboldt-Universität zu Berlin
3
Salvatore Crisafulli
University of Verona
4
Che-Cheng Chang
Fu Jen Catholic University
5
Laura Diez Porras
Hospital Clínic de Barcelona
6
Francesca Beretta
University of Milan
7
Qing Zhang
Zhejiang University of Technology
8
E. Harlan Michelle
Johns Hopkins University
9
Simone Birnbaum
Sorbonne Université
10
Lanqi Li
Guangzhou University of Chinese Medicine

Rising Stars Papers

1
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future
CNS Drugs|2024
34 cit.
2
Efgartigimod in refractory autoimmune myasthenia gravis
Muscle & Nerve|2024
20 cit.
3
Explainable machine learning model for identifying key gut microbes and metabolites biomarkers associated with myasthenia gravis
Computational and Structural Biotechnology Journal|2024
13 cit.
4
Machine learning-based algorithms applied to drug prescriptions and other healthcare services in the Sicilian claims database to identify acromegaly as a model for the earlier diagnosis of rare diseases
Scientific Reports|2024
7 cit.
5
Development of a Machine Learning Algorithm to Correlate Lumbar Disc Height on X-rays with Disc Bulging or Herniation
Diagnostics|2024
6 cit.
6
Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes
Annals of Internal Medicine|2025
4 cit.
7
Epidemiological analysis to identify predictors of X-linked hypophosphatemia (XLH) diagnosis in an Italian pediatric population: the EPIX project
Endocrine|2024
1 cit.
8
Le muscle : un organe extraordinaire
Kinésithérapie la Revue|2024
0 cit.
9
Frauen und Wohnungslosigkeit
Sozialpsychiatrische Informationen|2025
0 cit.
10
An Italian Multicenter Study on the Clinical and Serologic Characteristics of Seronegative Myasthenia Gravis (P6-11.028)
Neurology|2025
0 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Raghav Govindarajan
American Academy of Neurology
2
Jing He
Gansu University of Traditional Chinese Medicine
3
Nils G. Margraf
University Hospital Schleswig-Holstein
4
Tsutomu Kamo
Kawasaki Hospital
5
Carlo Alberto Artusi
University of Turin
6
Shirley Lasch
Institute for Neurodegenerative Disorders
7
Chelsea Caspell‐Garcia
University of Iowa
8
Maurizio Zibetti
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino
9
Haruki Funao
International University of Health and Welfare
10
Jean‐Luc Houéto
Inserm

Emerging Leaders Papers

1
Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis
Science Advances|2022
222 cit.
2
Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome
JAMA Network Open|2022
88 cit.
3
Dilemma of immunosuppression and infection risk in systemic lupus erythematosus
Lara D. Veeken|2023
50 cit.
4
Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy: New Data and Quantitative Meta-Analysis
Frontiers in Aging Neuroscience|2022
37 cit.
5
Time to onset and duration of botulinum toxin efficacy in movement disorders
Journal of Neurology|2022
35 cit.
6
Clusterin-carrying extracellular vesicles derived from human umbilical cord mesenchymal stem cells restore the ovarian function of premature ovarian failure mice through activating the PI3K/AKT pathway
Stem Cell Research & Therapy|2024
28 cit.
7
Delirium on stroke units: a prospective, multicentric quality-improvement project
Journal of Neurology|2022
26 cit.
8
Neurofilament light (NfL) as biomarker in serum and CSF in status epilepticus
Journal of Neurology|2023
24 cit.
9
How resistant are levodopa‐resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease
European Journal of Neurology|2022
20 cit.
10
Should we offer deep brain stimulation to Parkinson’s disease patients with GBA mutations?
Frontiers in Neurology|2023
17 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Shuu‐Jiun Wang
National Yang Ming Chiao Tung University
2
Antonia Barke
Philipps University of Marburg
3
Donald B. Sanders
Duke University
4
Richard J. Barohn
University of Missouri
5
Joseph Jankovic
Baylor College of Medicine
6
Frederick W. Miller
National Institute of Environmental Health Sciences
7
Gunda I. Georg
University of Minnesota
8
Günther Deuschl
Christian-Albrechts-Universität zu Kiel
9
Sudhansu Chokroverty
Hackensack Meridian Health
10
Bastiaan R. Bloem
Radboud University Nijmegen

Current Senior Leaders Papers

1
A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease
New England Journal of Medicine|2006
2.9k cit.
2
A classification of chronic pain for ICD-11
Pain|2015
2.8k cit.
3
Neurostimulation for Parkinson's Disease with Early Motor Complications
New England Journal of Medicine|2013
1.4k cit.
4
Variable expression of Parkinson's disease
Neurology|1990
1.3k cit.
5
The Parkinson Pandemic—A Call to Action
JAMA Neurology|2017
1.1k cit.
6
Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action
Unknown Journal|1998
983 cit.
7
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
Medicine|1991
973 cit.
8
Prospective assessment of falls in Parkinson's disease
Journal of Neurology|2001
873 cit.
9
Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study
The Lancet Neurology|2008
647 cit.
10
Myasthenia gravis: recommendations for clinical research standards
The Annals of Thoracic Surgery|2000
642 cit.

Reagents for Parkinson's Disease and Spinal Disorders

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling Technology

Phospho-Ubiquitin (Ser65) (E2J6T) Rabbit Monoclonal Antibody

#62802$2,221,157
View Evidence →
Cell Signaling Technology

PYURF (F9F4X) Rabbit Monoclonal Antibody

#16847$161,376
View Evidence →
Cell Signaling Technology

Phospho-NMDA Receptor 2B (GluN2B) (Tyr1070) Antibody

#4209$362
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 65

Merlin/Ezrin/Radixin/Moesin (D1P8I) Rabbit Monoclonal Antibody

#23292$161,351
View Evidence →
Acris AntibodiesEvidence 60

Mouse Anti-Canine Distemper Virus Monoclonal Antibody, Unconjugated, Clone 39937

#3CD10-5-4
View Evidence →
Acris Antibodies

Mouse Anti-CD154 / CD40L Monoclonal Antibody, Unconjugated Clone 2A3

#4CD40-2A3
View Evidence →